Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Simon Kennon
Research Area(s) / Expertise:

Structural Intervention

 Job title: Consultant Cardiologist
Dr Simon Kennon qualified from Manchester Medical School in 1992. He completed general medical training in and around London (Royal Free Hospital, Southend General Hospital, Newham General Hospital and the London Chest Hospital) before training in General and Interventional Cardiology at St Bartholomew’s and the London Chest Hospitals. His training continued with a fellowship in interventional… View more
Research Area(s) / Expertise:

Atrial Fibrillation

 Job title: Professor of Medicine and Director of Electrophysiology
Dr Hugh Calkins isProfessor of Medicine and Director of Electrophysiology at the Johns Hopkins Medical Institution in Baltimore, US. He has clinical and research interests in the treatment of cardiac arrhythmias with catheter ablation, the role of device therapy for treating ventricular arrhythmias, the evaluation and management of syncope and the study of arrhythmogenic right ventricular… View more
Recently, his participating in the executive education course “Managing Health Care Delivery” at Harvard Business School, Boston, USA, helped him to co-initiate and start the Sub-Saharan Africa (SSA) Academy to spread awareness for, and setup training programs in, vascular disease and aortic pathology in several less developed countries in Africa. In 2007 he was appointed as Professor and… View more
Job title: Staff Cardiologist, Interventional Cardiology
DrBenson graduated from the Chicago Medical School in 1974. His first two years of paediatric training took place at The Hospital for Sick Children in Toronto,and in 1976 was senior resident at St. Christopher’s Hospital for Children in Philadelphia. Subsequently, he returned to Toronto for Cardiology fellowship at The Hospital for Sick Children,and in 1979 entered graduate school at UCLA Medical… View more
HFA 2026: AC01 in HFrEF — Safety and Efficacy from GOAL-HF1
Author(s): Lars H Lund Added: 1 month ago
HFA Congress 2026 — Dr Lars Lund (Karolinska Institute and Karolinska University Hospital, Stockholm, SE) joins us to discuss findings from GOAL-HF1, a randomised, double-blind, placebo-controlled phase 1b/2a trial evaluating AC01 in patients with heart failure with reduced ejection fraction (HFrEF).This first-in-patient study assessed the safety, tolerability and exploratory efficacy of AC01 — a… View more

Heart Failure
Job title: Chief of the Division of Vascular Surgery and Director of the Center for Vascular Intervention
Job title: Associate Professor of Medicine
Dr Paul A Friedman is a cardiac electrophysiologist, cardiologist and Chair of Cardiovascular Medicine at Mayo Clinic, Rochester, Minnesota.Dr Friedman has extensive expertise in cardiac rhythm management, implantable cardiac devices, digital health and AI-enabled cardiovascular diagnostics. He previously served as Director of the Cardiac Implantable Device Lab at Mayo Clinic.A trained electrical… View more
Perry Elliott
Research Area(s) / Expertise: Job title: Director of UCL Institute of Cardiovascular Science and Professor of Cardiovascular Medicine
Professor Perry Mark Elliott was born on December 7, 1963, in London.6 He is a Professor of Cardiovascular Medicine at University College London (UCL) and a Senior Investigator of the UK National Institute for Health Research (NIHR).He is Director of the UCL Centre for Heart Muscle Disease, Head of Clinical Research at the Institute of Cardiovascular Science UCL and a consultant cardiologist in… View more
ICOS-CORE Whitepaper Calls for Rigorous Evidence to Support Cardio-oncology Rehabilitation
Added: 10 months ago Source:  Radcliffe Cardiology
A new whitepaper from the International Cardio-Oncology Society (ICOS) CORE working group outlines a critical roadmap for advancing the cardiovascular care of cancer survivors. Published in the European Heart Journal, the paper reviews the current evidence for cardio-oncology rehabilitation and exercise (CORE) programmes and sets new standards for future research to address significant knowledge… View more

Prevention & Chronic Conditions

CV Disease in Special Populations
Treatment Landscape for Cardiac Amyloidosis with Dr Sarah Cuddy
Author(s): Added: 9 months ago
Discover the rapidly evolving therapeutic options transforming outcomes for cardiac amyloidosis patients with Dr Sarah Cuddy.This comprehensive presentation, part of the Cardiomyopathies track, explores the dramatic advances in both TTR and AL amyloidosis treatment over the past decade. Dr Cuddy examines how modern therapeutic approaches have fundamentally shifted survival curves, particularly… View more

Heart Failure